Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Dose-Frequency Escalation Study of Neoadjuvant Cryotherapy in Locally Advanced Esophageal Cancer

NCT04248582 is registered in ClinicalTrials.gov with Hunter Holmes Mcguire Veteran Affairs Medical Center as lead sponsor.

NCT NCT04248582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04248582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Dose-Frequency Escalation Study of Neoadjuvant Cryotherapy in Locally Advanced Esophageal Cancer
Lead sponsor
Hunter Holmes Mcguire Veteran Affairs Medical Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
February 11, 2020
Completion date
March 1, 2027
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer